Back

State-of-the-art lipid-lowering combination therapies.

29 August 2017 (12:55 - 13:05)
Organised by:
Congress Presentation Part of: State-of-the-art lipid treatment in coronary patients in 2017 Lipids (Epidemiology and Prevention) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Francois Mach

University hospitals of Geneva, Geneva (Switzerland)

4 More presentations in this session

Presentation thumbnail
A clinician's perspective on recent guidelines in clinical practice.
Doctor M. Bonaca (Aurora, US)
Presentation thumbnail
Emerging science: recent evidence and science on the horizon.
Professor E. Braunwald (Boston, US)
Presentation thumbnail
Successes and challenges in clinical practice.
Doctor C. Ballantyne (Houston, US)
Presentation thumbnail
Audience Q&A - State-of-the-art-lipid treatment in coronary patients in 2017.
Doctor M. Bonaca (Aurora, US) Professor E. Braunwald (Boston, US) Professor F. Mach (Geneva, CH)

Access the full session

Session thumbnail
State-of-the-art lipid treatment in coronary patients in 2017

The Event

Event poster

ESC Congress 2017

29 August 2017 12:55 CET
You may be interested in
thumbnail
Congress Presentation
Forging the path: strategic combinations to achieve lipid targets
29 August 2025
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025
thumbnail
Webinar
Update of the 2019 ESC Guidelines on Management of Dyslipidaemia: new recommendations and their impact on clinical practice
25 November 2025
thumbnail
Congress Presentation
Targeting RNA for treatment of dyslipidaemias.
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources